| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.562 | 28.640 | 32.163 | 33.942 | 70.221 | 38.819 | 39.752 | 54.104 | 61.485 | 76.924 |
| Total Income - EUR | 15.562 | 28.640 | 32.163 | 33.942 | 70.222 | 38.819 | 39.752 | 54.104 | 61.485 | 77.060 |
| Total Expenses - EUR | 20 | 13.947 | 22.943 | 27.433 | 29.689 | 35.626 | 37.844 | 32.443 | 35.264 | 45.094 |
| Gross Profit/Loss - EUR | 15.542 | 14.693 | 9.220 | 6.509 | 40.533 | 3.193 | 1.909 | 21.661 | 26.221 | 31.966 |
| Net Profit/Loss - EUR | 15.074 | 13.363 | 8.761 | 5.923 | 40.533 | 3.193 | 1.909 | 20.273 | 24.285 | 29.374 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Takayama Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.548 | 28.285 | 36.568 | 41.841 | 155.970 | 83.238 | 218 | 99.352 | 123.336 | 158.864 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 15.562 | 28.284 | 36.577 | 41.841 | 155.977 | 83.240 | 210 | 99.350 | 123.334 | 158.862 |
| Cash | -13 | 1 | -9 | 0 | -6 | -2 | 7 | 2 | 2 | 2 |
| Shareholders Funds | 11.392 | 24.638 | 32.983 | 38.300 | 78.092 | 79.804 | 79.943 | 99.352 | 123.336 | 152.020 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 4.157 | 3.647 | 3.585 | 3.541 | 77.879 | 3.433 | -79.726 | 0 | 0 | 6.843 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Takayama Med Srl